The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer’s Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miR-29b was contained in the exosomes.
“miR-29b was contained in the exosomes and its target genes included BACE1 and BIM [104] (Table 6).”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [104]
miR-29b target genes included BACE1 and BIM.
“miR-29b was contained in the exosomes and its target genes included BACE1 and BIM [104] (Table 6).”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [104]
The injection of miR-29b-containing exosomes reduced the pathological effects of Aβ in a rat model of AD.
“The injection of miR-29b-containing exosomes reduced the pathological effects of Aβ in a rat model of AD [104].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943
Alzheimer's disease: experimental models and reality
Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810
Zhuang, X., Teng, Y., Samykutty, A., Mu, J., Deng, Z., Zhang, L., Cao, P., Rong, Y., Yan, J., Miller, D., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.188 · Cited by 294
New Approaches for the Treatment of Alzheimer’s Disease
Fish, P. V., Steadman, D., Bayle, E. D., & Whiting, P. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.11.034 · Cited by 189
Monfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123
Self-citationFaucher, P., Mons, N., Micheau, J., Louis, C., & Beracochea, D. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00245 · Cited by 100
Flagged first, then by citations
Research works printed but not linked: 44
- Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes., Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
- Andaloussi, 2013, Extracellular vesicles: biology and emerging therapeutic opportunities., Nat. Rev. Drug Discov., 12, 347, 10.1038/nrd3978 · DOI · Paper page
- Chen, 2018, RNA interference-based therapy and its delivery systems., Cancer Metastasis Rev., 37, 107, 10.1007/s10555-017-9717-6 · DOI
- Chow, 2010, An overview of APP processing enzymes and products., Neuromol. Med., 12, 1, 10.1007/s12017-009-8104-z · DOI · Paper page
- Drachman, 2014, The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer’s disease., Alzheimer’s Dement., 10, 372, 10.1016/j.jalz.2013.11.003 · DOI · Paper page
- Femminella, 2015, The emerging role of microRNAs in Alzheimer’s disease., Front. Physiol., 6, 10.3389/fphys.2015.00040 · DOI
- Gebert, 2018, Regulation of microRNA function in animals., Nat. Rev. Mol. Cell Biol., 20, 21, 10.1038/s41580-018-0045-7 · DOI · Paper page
- Geng, 2010, Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats., Biol. Pharm. Bull., 33, 836, 10.1248/bpb.33.836 · DOI
- Gnecchi, 2016, Paracrine mechanisms of mesenchymal stem cells in tissue repair., Mesenchymal Stem Cells, 1416, 123, 10.1007/978-1-4939-3584-0_7 · DOI
- György, 2011, Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles., Cell. Mol. Life Sci., 68, 2667, 10.1007/s00018-011-0689-3 · DOI
- Hardy, 2002, The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics., Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Hébert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/β-secretase expression., Proc. Natl. Acad. Sci. U.S.A., 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
- Kasza, 2017, Studies for improving a rat model of Alzheimer’s disease: icv administration of well-characterized β-amyloid 1-42 oligomers induce dysfunction in spatial memory., Molecules, 22, 10.3390/molecules22112007 · DOI
- Kole, 2011, miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis., Genes Dev., 25, 125, 10.1101/gad.1975411 · DOI
- Li, 2012, Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis., Stem Cells Dev., 22, 845, 10.1089/scd.2012.0395 · DOI
- Lippi, 2011, Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology., J. Cell Biol., 194, 889, 10.1083/jcb.201103006 · DOI
- Liu, 2015, Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse., Sci. Rep., 5, 10.1038/srep17543 · DOI
- Lu, 2017, Exosome-based small RNA delivery: progress and prospects., Asian J. Pharm. Sci., 13, 1, 10.1016/j.ajps.2017.07.008 · DOI · Paper page
- Mathiyalagan, 2017, Exosomes-based gene therapy for microRNA delivery., Methods Mol. Biol., 1521, 139, 10.1007/978-1-4939-6588-5_9 · DOI
- Morel, 2015, Cognitive impairment and morphological changes in the dorsal hippocampus of very old female rats., Neuroscience, 303, 189, 10.1016/j.neuroscience.2015.06.050 · DOI
- Mu, 2011, Adult hippocampal neurogenesis and its role in Alzheimer’s disease., Mol. Neurodegener., 6, 10.1186/1750-1326-6-85 · DOI · Paper page
- Nunez-Iglesias, 2010, Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer’s disease cortex reveals altered miRNA regulation., PLoS One, 5, 10.1371/journal.pone.0008898 · DOI
- Paxinos, 2006, The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition.
- Pearson-Leary, 2012, Intrahippocampal administration of amyloid-β 1-42 oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism., J. Alzheimer’s Dis., 30, 413, 10.3233/jad-2012-112192 · DOI
- Pereira, 2016, Recombinant pre-miR-29b for Alzheimer ‘s disease therapeutics., Sci. Rep., 6, 10.1038/srep19946 · DOI
- Pitts, 2018, Barnes maze procedure for spatial learning and memory in mice., Bio Protoc., 8, 10.21769/BioProtoc.2744 · DOI
- Rani, 2015, Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications., Mol. Ther., 23, 812, 10.1038/mt.2015.44 · DOI
- Record, 2011, Exosomes as intercellular signalosomes and pharmacological effectors., Biochem. Pharmacol., 81, 1171, 10.1016/j.bcp.2011.02.011 · DOI
- Roshan, 2014, Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice., RNA, 20, 1287, 10.1261/rna.044008.113 · DOI
- Scott, 2007, Dementia syndromes: evaluation and treatment., Expert Rev. Neurother., 7, 407, 10.1586/14737175.7.4.407 · DOI
- Selkoe, 2001, Alzheimer’s disease: genes, proteins, and therapy., Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- Shioya, 2010, Aberrant microRNA expression in the brains of neurodegenerative diseases: miR−29a decreased in Alzheimer disease brains targets neurone navigator 3., Neuropathol. Appl. Neurobiol., 36, 320, 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
- Simons, 2009, Exosomes–vesicular carriers for intercellular communication., Curr. Opin. Cell Biol., 21, 575, 10.1016/j.ceb.2009.03.007 · DOI
- Sokolova, 2011, Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy., Colloids Surf. B Biointerf., 87, 146, 10.1016/j.colsurfb.2011.05.013 · DOI
- Soleimani, 2008, A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow., Nat. Protoc., 4, 102, 10.1038/nprot.2008.221 · DOI
- Soo, 2012, Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells., Immunology, 136, 192, 10.1111/j.1365-2567.2012.03569.x · DOI
- Théry, 2009, Membrane vesicles as conveyors of immune responses., Nat. Rev. Immunol., 9, 581, 10.1038/nri2567 · DOI
- Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells., Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
- Wang, 2015, Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele., Stem Cells Transl. Med., 4, 659, 10.5966/sctm.2014-0296 · DOI
- Yamashita, 2018, Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application., Biol. Pharm. Bull., 41, 835, 10.1248/bpb.b18-00133 · DOI
- Yang, 2015, MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo., Mol. Med. Rep., 12, 3081, 10.3892/mmr.2015.3728 · DOI
- Zhuang, 2011, Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain., Mol. Ther., 19, 1769, 10.1038/mt.2011.164 · DOI · Paper page
- Zong, 2011, miR-29c regulates BACE1 protein expression., Brain Res., 1395, 108, 10.1016/j.brainres.2011.04.035 · DOI · Paper page
- Zong, 2015, miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer’s disease., Brain Res., 1624, 95, 10.1016/j.brainres.2015.07.022 · DOI
Cited by
Sorted by citations
Xu, M., Feng, T., Liu, B., Qiu, F., Xu, Y., Zhao, Y., & Zheng, Y. (2021) · Theranostics · doi:10.7150/thno.62330 · Cited by 229
Emerging prospects of extracellular vesicles for brain disease theranostics
Wang, R., Wang, X., Zhang, Y., Zhao, H., Cui, J., Li, J., & Di, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.024 · Cited by 48
Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases
Meldolesi, J. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00040-5 · Cited by 47
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
Li, W., & Zheng, Y. (2023) · Cells · doi:10.3390/cells12101378 · Cited by 43
Muolokwu, C. E., Chaulagain, B., Gothwal, A., Mahanta, A. K., Tagoe, B., Lamsal, B., & Singh, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1405423 · Cited by 42
Liu, X., Shen, L., Wan, M., Xie, H., & Wang, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02428-1 · Cited by 33
Metadata
- Authors
- Jahangard, Y., Monfared, H., Moradi, A., Zare, M., Mirnajafi-Zadeh, J., & Mowla, S. J.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-06-18
- Volume
- 14
- ISSN
- 1662-453X
- PMC
- PMC7314926
- Cited by
- 162
- References
- 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review